Buscar

Filtros actuales:


Comenzar nueva busqueda
Añadir filtros:

Usa los filtros para afinar la busqueda.


Resultados 1-6 de 6.
  • Anterior
  • 1
  • Siguiente
Resultados por ítem:
Vista previaFecha de publicaciónTítuloAutor(es)Acceso
Food ProteineInduced Enterocolitis Syndrome in.pdf.jpgsep-2022Food ProteineInduced Enterocolitis Syndrome in Adulthood: Clinical Characteristics, Prognosis, and Risk Factors
González-Delgado, Purificación; Muriel, Javier; Jiménez, Teodorikez; Cameo, José Ignacio; Palazón-Bru, Antonio; Fernández, Javier
Oxycodonenaloxone.naxolone  versus tapentadol in real world chronic non‑cancer pain.pdf.jpg2022Oxycodone/naloxone versus tapentadol in real‑world chronic non‑cancer pain management: an observational and pharmacogenetic study
Barrachina, Jordi; Margarit, Cesar; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana María
Sex-Differences in Pain and Opioid Use Disorder Management.pdf.jpg2022Sex-Differences in Pain and Opioid Use Disorder Management: A Cross-Sectional Real-World Study
Escorial, Mónica; Muriel, Javier; César, Margarit; Laura, Agulló; Domingo, Morales; Peiró, Ana
Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpgjun-2022Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana
Long-term deprescription in chronic pain and opioid use disorder patients. Pharmacogenetic and sex differences.pdf.jpg18-nov-2022Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana
CYP2D6 phenotypes and opioid metabolism. the path to personalised analgesia.pdf.jpgabr-2022CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesiaBallester, Purificación; Muriel, Javier; Peiró, Ana